Trial Profile
An Observational Study to Determine the In-vitro Immunologic and Virology Activity of Cytolin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Anti-CD8 monoclonal antibody (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors CytoDyn
- 06 Jun 2014 New trial record